Fosaprepitant

Category: Nausea & Vomiting



Fosaprepitant Overview

Fosaprepitant (Emend for Injection (US), Ivemend (EU)) is an antiemetic medication, administered intravenously. It is a prodrug of aprepitant. Fosaprepitant was developed by Merck & Co. and was approved by the U.S. Food and Drug Administration (FDA) on January 25, 2008,[1] and by the European Medicines Agency (EMA) on January 11 of the same year.[2] References .mw-parser-output .reflist{font-size:90%;margin-bottom:0.5em;list-style-type:decimal}.mw-parser...

Read more Fosaprepitant Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Fosaprepitant

Recent Fosaprepitant Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Fosaprepitant
  • Capsule: 125mg, 40mg, 80mg, 80mg + 125mg
  • Emulsion: 130mg/18ml (7.2mg/ml)
  • For Suspension: 125mg/kit
  • Injection: 130mg, 150mg/vial
  • Powder: 115mg/vial, 150mg/vial
  • Solution: 125mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Fosaprepitant: (29 results)

Showing the first 20, Sorted by National Drug Code
  • 0338-0008 Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Baxter Healthcare Corporation
  • 0591-4385 Fosaprepitant 150 mg Intravenous Injection, Powder, Lyophilized, for Solution by Actavis Pharma, Inc.
  • 0781-3497 Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Sandoz Inc.
  • 16714-120 Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Northstar Rxllc
  • 16714-929 Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Northstar Rxllc
  • 16729-240 Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Accord Healthcare Inc.
  • 25021-784 Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Sagent Pharmaceuticals
  • 31722-165 Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Camber Pharmaceuticals, Inc.
  • 43598-859 Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Dr. Reddy's Laboratories Inc.,
  • 43598-948 Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Dr. Reddy's Laboratories Inc.,
  • 60505-6105 Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Apotex Corp
  • 63323-972 Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Fresenius Kabi USA, LLC
  • 67457-888 Fosaprepitant 115 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Mylan Institutional LLC
  • 67457-889 Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Mylan Institutional LLC
  • 68001-421 Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Bluepoint Laboratories
  • 68001-517 Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Bluepoint Laboratories
  • 68180-690 Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Lupin Pharmaceuticals, Inc.
  • 69097-830 Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Cipla USA Inc.
  • 69539-034 Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Msn Laboratories Private Limited
  • 69539-181 Fosaprepitant 150 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Msn Laboratories Private Limited
  • 9 more results ...

Other drugs which contain Fosaprepitant or a similar ingredient: (4 results)